{"tid":1067419,"cid":5,"subCid":0,"title":"證監會譴責中銀國際銷售投資產品違規　罰1000萬元","createTime":"2019-03-18T13:32:30.000Z","updateTime":"2019-03-19T10:27:36.000Z","uid":79563,"like":2,"dislike":0,"uniUserReply":2,"replies":[{"pid":"6bbeda880861a46dc99e93b525c1bfae9062092b","tid":1067419,"uid":79563,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2019-03-18T13:32:31.000Z","msg":"<img src=\"https://fs.mingpao.com/fin/20190318/s00010/a1dc9358d00d3e73a5460182f05a789e.jpg\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Ffs.mingpao.com%2Ffin%2F20190318%2Fs00010%2Fa1dc9358d00d3e73a5460182f05a789e.jpg&h=d59e9e89&s={SIZE}\" /><br />\n<br />\n上星期才重罰4間投行的證監會，今日又再出手，指中銀國際在銷售投資產品的手法出現內部系統和監控缺失，對其作出譴責及罰款1000萬元。<br />\n<br />\n證監會指，中銀國際在銷售和分銷投資產品時，沒有遵守有關客戶風險分析、產品盡職審查及合適性評估的多項監管規定。其中，證監會的調查顯示，中銀國際進行客戶風險評估後，客戶如不同意評估結果，可提高或降低投資風險的級別而不需要提供任何理據，結果導致有超過三分之一應該屬於投資策略與產品風險評級錯配的交易，被中銀國際當作沒有錯配。<br />\n<br />\n另外，證監會認為，中銀國際在產品盡職審查及合適性評估程序方面亦存在缺失。"},{"pid":"ed5510bf372132e2a96dd9d1f8da805ad713ee9f","tid":1067419,"uid":18955,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2019-03-18T13:36:46.000Z","msg":"執十億八億<br />\n<br />\n比你抽一千萬水<br />\n<br />\n有錢齊齊搵<br />\n<br />\nSuper<img src=\"/assets/faces/pig/smile.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/pig/hehe.gif\" class=\"hkgmoji\" />"},{"pid":"035602b6e96589fd66285ae1dba8993e2c1c6436","tid":1067419,"uid":79563,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2019-03-19T10:27:36.000Z","msg":"<img src=\"/assets/faces/dog/smile.gif\" class=\"hkgmoji\" />"}]}